Vaxxinity published data Thursday showing that its experimental immunotherapy could improve daily movement in Parkinson’s patients and elicit antibodies against a toxic protein involved in the disease process.
SMITM CAPITAL MARKETS LTD. has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc., entailing a capital commitment of $5 million to fuel MABT’s groundbreaking efforts to combat rabies.
Dizal announced that the National Medical Products Administration of China has approved golidocitinib for the treatment of adult patients with relapsed or refractory (r/r) peripheral T-Cell lymphoma (PTCL) whose disease has progressed on or were refractory to at least 1 prior systemic therapy.
The Tang Prize Foundation announced the 2024 Tang Prize in Biopharmaceutical Science recipients. The prestigious award has been jointly awarded to Joel F. Habener, Svetlana Mojsov, and Jens Juul Holst, for the discovery of GLP-1 (7-37) as an insulinotropic factor and the development of GLP-1 (7-37)-based anti-diabetic and anti-obesity drugs.
Johnson & Johnson is facing a new proposed class action seeking damages and medical monitoring on behalf of women who have been diagnosed with cancer, or might develop it in the future, allegedly as a result of using the company’s baby powder and other talc products.
Michigan will offer dairy operations with bird flu up to $28,000 to work with federal and state government agencies to investigate how the virus got onto their operations, Michigan Department of Agriculture and Rural Development Director Tim Boring said on Tuesday.